GCL
IQMDU

Glazer Capital LLC’s Intelligent Medicine Acquisition Corp. Unit IQMDU Stock Holding History

Glazer Capital LLC’s Portfolio IQMDU Stock Details IQMDU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-46,831
Closed -$478K – 770
2021
Q4 		$478K Buy
+46,831
New +$475K 0.01% 492

Other funds holding IQMDU

Calamos Advisors
Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return
HIM
HGC Investment Management Toronto, Ontario, Canada $507M AUM 6.15% 1-Year Est. Return
CCA
Castle Creek Arbitrage Avon, Colorado $425M AUM 7.4% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.52B AUM 36.54% 1-Year Est. Return
WC
Wealthspring Capital West Harrison, New York $448M AUM 8.38% 1-Year Est. Return
SFM
Spartan Fund Management Toronto, Ontario, Canada $30M AUM 11.98% 1-Year Est. Return
DCM
Difesa Capital Management New York $38.1M AUM 39.86% 1-Year Est. Return

Glazer Capital LLC's IQMDU Position: Q1 2022 in Review

Glazer Capital LLC sold out of Intelligent Medicine Acquisition Corp. Unit (IQMDU) in Q1 2022, closing a stake of 46,831 shares — an estimated $478K sold.

Glazer Capital LLC first reported a position in IQMDU in Q4 2021 and held it in 1 quarter. The position peaked at $478K in Q4 2021. 26 funds tracked by Wall St. Rank hold IQMDU as of Q1 2022.

  • Glazer Capital LLC reported no remaining Intelligent Medicine Acquisition Corp. Unit position as of Q1 2022 after selling out during the quarter.
  • Glazer Capital LLC sold 46,831 Intelligent Medicine Acquisition Corp. Unit shares in Q1 2022, an estimated $478K.
  • Glazer Capital LLC first reported a position in Intelligent Medicine Acquisition Corp. Unit in Q4 2021 and held it in 1 quarter.
  • Glazer Capital LLC's Intelligent Medicine Acquisition Corp. Unit position peaked at $478K in Q4 2021.
  • 26 funds tracked by Wall St. Rank held Intelligent Medicine Acquisition Corp. Unit as of Q1 2022.

Based on Glazer Capital LLC's 13F filing for Q1 2022, filed 17 May 2022.